Rank #1: Justin Klein, MD, JD, Partner at New Enterprise Associates
Feb 29 2016
Rank #2: Advice of the Valkyrie – GE Venture’s Lisa Suennen Explains How Medtechers Can Find Their Voice
Apr 06 2017
Rank #3: Foundry’s Gifford: Innovating Innovation in a Changing Health Care World
Apr 23 2015
Rank #4: Mahoney Shares What Surprised Him at Boston Scientific and How the Company Turned Around its Culture
Jul 13 2017
Rank #5: HealthQuest’s Kong on teamwork, Medtech, and investing $225 million
Mar 30 2016
Rank #6: How Will CEO Pavlidis Help VytronUS Deliver Disruptive Ultrasound Tool to Treat Afib in the EP Lab?
Nov 03 2017
Rank #7: Intersect ENT CEO Lisa Earnhardt Discusses New Products and Plans as Medtech Talk Hits the 100 Mark
Apr 10 2018
Rank #8: How Will Abbott & Auris Deals Impact Early Stage Start-ups?
May 03 2016
Rank #9: Invus Opportunities Partner Ben Tsai Seeks – and Finds – Success in Medtech Investments
Benjamin Tsai says his initial plans – or the plans he’d been given – called on him being a doctor. But he quickly saw a greater opportunity working in the life sciences industry. Tsai made a quick run through consulting firms and business school before finding a place at Invus, an investment firm that has operated mostly out of the limelight. In this podcast, Tsai discusses his career, his outlook on Medtech and why Invus – investor in Auris Health and other high-profile deals – is beginning to get out to tell its own story.
Mar 22 2019
Rank #10: Endeavour Vision’s Ellias Reveals the Path from Pre-Med to Medtronic to Investing in Medtech
Aug 04 2017
Rank #11: CEO Stevens Says HeartFlow Took No Shortcuts to Commercialization, Raising $240 million Series E
Overview: HeartFlow has built a strong financial argument for its imaging system.
Surprises: This stuff belongs on Star Trek. Very cool.
Takeaway: "There are no shortcuts."
Mar 06 2018
Rank #12: Stanford’s Yock Talks Medtech Costs, Biodesign’s Birthday, and How He Feels about Apple and Google
May 03 2017
Rank #13: Managing Director Kirk Nielsen Talks Origins, Medtech, and Versant Ventures’ new $400 Million Fund
Mar 17 2017
Rank #14: Cardionomic’s Goedeke Talks Team Jackets, Ski Lifts, and Changing How ADHF Is Treated
Nov 10 2017
Rank #15: New Metavention CEO Todd Berg Talks M&A, Raising Capital, and Why He’s Excited to Join the Start-up
Berg worked at three Medtech start-ups prior to accepting the CEO post at exciting new start-up Metavention, and all three companies would be acquired including Torax Medical, the GERD company Berg led from start to finish.
What led Berg to Medtech? Why did he co-found Torax? How did he find success raising capital? How is he approaching his new challenge leading Metavention, which is developing a novel, new potential treatment for type 2 diabetes?
Jan 23 2018
Rank #16: Baxter Ventures VP Anne Sissel Says Strategic Investors Can Help Start-Ups Reach Their Potential
Apr 04 2018
Rank #17: FundRx Finding the Formula to Bring LPs, VCs, Individuals to Fund Promising Medtech Start-Ups
Feb 24 2017
Rank #18: Rohlen Explains How KKR, Ajax Are Rethinking How We Run Medtech Start-ups
Jun 08 2017
Rank #19: Santé Ventures’ James Eadie, MD, Reveals the Early-Stage Strategy That’s Producing Epic Returns
Santé Ventures partner James Eadie, MD, doesn’t recall the good old days of Medtech. He joined the Austin-based Venture Firm after two tours in Iraq with the Air Force where he led an ER and served as part of a “flying ICU,” airlifting wounded soldiers out of combat zones. Upon returning to the states, Eadie recognized his desire to run a company could be satisfied by investing in early-stage medical device firms, and he’s developed an impressive record over that span backing companies including TVA Medical, Claret Medical, and Millipede – three companies that could ultimately secure close to a billion dollars in M&A. In this podcast you’ll hear how Santé views early-stage ideas, including those literally drawn up on napkins. Does Santé bet on the jockey or the horse? We’ll let Eadie answer that one.
Feb 07 2019
Rank #20: Klein Shares how NEA Plans to Put More Than $300 Million to Work in Medtech Companies
Jun 26 2017